Title:
PHARMACEUTICAL COMBINATION OF 1,3,5-TRIAZINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2024/008138
Kind Code:
A1
Abstract:
A pharmaceutical combination of a 1,3,5-triazine derivative. Specifically, the present invention relates to a pharmaceutical combination of a compound of formula I, a tautomer thereof or a pharmaceutically acceptable salt thereof, and azacitidine, and the pharmaceutical use thereof.
Inventors:
TU LIFAN (CN)
YAN HUI (CN)
ZHANG XIQUAN (CN)
WANG XUNQIANG (CN)
YU DING (CN)
LIU ZHI (CN)
YAN HUI (CN)
ZHANG XIQUAN (CN)
WANG XUNQIANG (CN)
YU DING (CN)
LIU ZHI (CN)
Application Number:
PCT/CN2023/106034
Publication Date:
January 11, 2024
Filing Date:
July 06, 2023
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
A61K31/53; A61K31/5377; A61K31/706; A61P35/00; C07D401/14
Domestic Patent References:
| WO2017016513A1 | 2017-02-02 |
Foreign References:
| CN109715143A | 2019-05-03 |
Attorney, Agent or Firm:
BEIJING SUNHOPE INTELLECTUAL PROPERTY LTD. et al. (CN)
Download PDF:
Previous Patent: PUMP DEVICE AND PLUNGER PUMP
Next Patent: OPTIMIZED METHOD FOR AMPLIFICATION AND PRODUCTION AT SCALE FOR REGULATORY T CELLS
Next Patent: OPTIMIZED METHOD FOR AMPLIFICATION AND PRODUCTION AT SCALE FOR REGULATORY T CELLS